Invitrogen™ RG1 Biosimilar Recombinant Monoclonal Antibody

Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA558949

Catalog No. MA558949

Description

For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °. This antibody can also be cross referenced by the term 19G9.

RG1 is a gene that has primarily been studied in the context of Ginsenoside Rg1, a bioactive compound derived from the roots of Panax ginseng. Ginsenoside Rg1 is known for its neuroprotective effects and regulatory role in immune responses. It modulates various signaling pathways, including the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which is crucial for cell survival and growth. Additionally, Rg1 has been shown to inhibit apoptotic pathways mediated by endoplasmic reticulum stress and the c-Jun N-terminal kinase (JNK) pathway in neurodegenerative disease models, potentially offering therapeutic benefits in conditions like Alzheimer's disease. Furthermore, Rg1 influences the activation of astrocytes through long non-coding RNAs (lncRNAs) and microRNAs, contributing to the repair of spinal cord injuries. Overall, RG1, through its association with Ginsenoside Rg1, plays a significant role in cellular protection and modulation across various biological systems.

Specifications

• Antigen: RG1 Biosimilar
• Classification: Recombinant Monoclonal
• Conjugate: Unconjugated
• Host Species: Human
• Quantity: 100 μg
• Primary or Secondary: Primary
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Form: Lyophilized

• Applications: ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
• Concentration: 1 mg/mL
• Formulation: 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2
• Purification Method: Protein A
• Regulatory Status: RUO
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG1